Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

SVR & Risk of T2D Among Patients with HCV

J Viral Hepat; ePub 2018 Feb 25; Li, Zhang, et al

Among a large US cohort of patients treated for hepatitis C virus (HCV), patients who achieved sustained virological response (SVR) demonstrated a substantially lower risk for development of type 2 diabetes mellitus (T2D) than patients with treatment failure. This according to a study that examined how response to HCV treatment impacts risk of subsequent T2D. Among HCV patients without a history of T2D or hepatitis B, researchers investigated incidence of T2D from 12 weeks post-HCV-treatment through December 2015. They found:

  • Among 5,127 patients with an average follow-up of 3.7 years, T2D incidence was significantly lower among patients who achieved SVR than among patients with treatment failure (6.2% vs 21.7%).
  • Risk of T2D was higher among African American and Asian American patients vs white patients (adjusted hazard ratio [aHR], 1.82 and 1.75, respectively).
  • Patients with body mass index (BMI) ≥30 and 25-20 demonstrated higher risk than those with BMI <25.
  • Cirrhosis at baseline was also a risk factor.

Citation:

Li J, Zhang T, Gordon SC, et al. Impact of sustained virological response on risk of type 2 diabetes among hepatitis C patients in the US. [Published online ahead of print February 25, 2018]. J Viral Hepat. doi:10.1111/jvh.12887.

This Week's Must Reads

Global Burden of CVD in People Living with HIV, Circulation; ePub 2018 Jul 2; Shah, et al

Penicillin Allergy & Risk of MRSA and C. difficle, BMJ; ePub 2018 Jun 27; Blumenthal, et al

Does Sleep Debt Decrease with Age? , Sleep Health; ePub 2018 Jun 28; Fox, et al

Firearm Injuries in Children & Adolescents, Pediatrics; ePub 2018 Jul 2; Herrin, et al

Effects of Pulse Pressure & BP Tx Intensity on AEs, Am J Med; ePub 2018 Jun 22; Krishnaswami, et al

Must Reads in Hepatitis

How to Improve HCV Treatment Access in the US, J Public Health Manag Pract; ePub 2018 Jun 20; Kapadia, et al

Hepatitis B and C & Risk of Liver Cancer, Open Forum Infect Dis; ePub 2018 Jun 16; Moore, et al

Barriers in the HCV Cascade of Care, PLoS One; ePub 2018 Jun 18; Zuckerman, et al

HCV Testing & Treatment Among PWID, Subst Use Misuse; ePub 2018 Jun 22; Boucher, et al

HCC Development After Viral Clearance in CHC , J Digest Dis; ePub 2018 Jun 11; Tong, et al